The Effectiveness of a Smartphone Application in the Treatment of Alcohol Use Disorder
Alcohol Use Disorder
About this trial
This is an interventional supportive care trial for Alcohol Use Disorder focused on measuring Alcohol Use Disorder, Smartphone Application
Eligibility Criteria
Inclusion Criteria:
- Patients will fulfil the criteria for an alcohol use disorder according to the Structured Clinical Interview for DSM-5 Axis I Disorders
- Patients must complete an alcohol treatment programme at St. Patrick's University Hospital.
- Primary addiction must be alcohol in poly-substance abusers.
- Aged over 18 years of age and capable of providing written, informed consent.
- Mini Mental State Examination (MSSE) score of ≥25.
- Patients must have an iphone or Android smartphone and are familiar with using smartphone applications.
Exclusion Criteria:
- Patients whose primary substance of abuse is not alcohol, although may meet the criteria for alcohol dependency/abuse.
- Patients who do not have an iPhone or Android smartphone.
- Age <18years or >70years.
- Psychotic disorder
- Patients who do not fully complete an inpatient treatment programme before discharge.
- History of alcohol use disorder but not current.
Sites / Locations
- St. Patrick's University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Smartphone Application Users
Control Group
The experimental group will receive the smartphone intervention along with treatment as usual for 3-months. The smartphone application (UControlDrink) includes twice daily text message recovery support, relapse prevention cognitive behavioural therapy, 12 sessions in total, drinking and recovery activity logs where participants detail their abstinence, drinking and recovery activity engagement on a daily basis. Craving intervention in the form of a "calm button" to deal with cravings and prevent relapse and gamification, a system of encouraging positive behaviour with the awarding of "points" to achieve various "status" levels, is used to increase adherence and compliance with treatment recommendations.
The control group will also receive treatment as usual, i.e. any follow-up after-care that they chose to participate in and regular AA/Lifering meetings.